Sphygmomanometer Market - By Product, By Operation, By Configuration, By End-use & Global Forecast, 2023

Description

Sphygmomanometer Market is anticipated to witness a positive trajectory from 2023 to 2032, as it has become one of the most crucial parts of patient care. Technological innovations in these modalities have resulted in efficient and more precise diagnoses delivery as per the requirements of modern medicine. In addition, several oscillometer devices that use electronic pressure sensors within the blood pressure cuff have been authorized for accurate blood pressure measurement in healthcare facilities. These advanced systems also help reduce human errors linked with auscultation.

Overall, the sphygmomanometer market is segmented in terms of product, operation, configuration, end-use, and region.

Based on the product, the mercury sphygmomanometer product segment is anticipated to be valued at over USD 91 million by 2032. The mercury sphygmomanometer has been the most preferred choice for monitoring blood pressure, which is anticipated to favor the segment outlook positively.

By operation, the automatic sphygmomanometers segment will exhibit over 10% CAGR through 2032. Increasing technological innovations and the rising focus of firms on novel product developments to fulfill the demand for digital solutions that enhance monitoring capabilities will drive business revenue.

Considering the configuration, the portable segment will grow considerably during the estimated timeframe. The surging geriatric population, rising awareness about preventive treatment, and increasing need for convenient blood pressure monitoring tools will push the portable sphygmomanometer market expansion.

In terms of end-user, the ambulatory surgical centers segment captured over 21% market share in 2022 and is anticipated to grow through 2032. Constantly rising cases of hypertension and hypotension will help ambulatory surgical centers seize considerable traction in the coming years. As per the WHO reports, approximately 1.28 billion adults aged between 30-79 years suffer from hypertension. Besides, the rising number of diagnostic procedures in these facilities is anticipated to augment the demand for sphygmomanometers in the coming years.

Geographically, the North America sphygmomanometer industry is slated to be valued at over USD 1.1 billion by 2032. Increasing adoption of unhealthy lifestyle resulting in hypertension, coupled with the constantly surging geriatric population base, will help the market expand in the future. The region will also demonstrate strong growth owing to the increasing investments undertaken by the regional companies in the research and development of medical devices. Besides, the rising prevalence of blood pressure-related disorders across the region will also contribute to the market expansion.

Product Code: 3651

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Sphygmomanometer industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Operation trends
- 2.1.4 Configuration trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends

Chapter 3 Sphygmomanometer Industry Insights

3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of cardiovascular disorders including hypertension
  - 3.2.1.2 Increase in average patient visits in healthcare settings
  - 3.2.1.3 Technological advancements in sphygmomanometers
  - 3.2.1.4 Growing geriatric population pool
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Decreasing adoption of mercury thermometer
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By operation
- 3.3.3 By configuration
- 3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Strategy dashboard, 2022

Chapter 5 Sphygmomanometer Market, By Product

5.1 Key product trends
5.2 Mercury Sphygmomanometer
- 5.2.1 Market size, by region, 2018 - 2032 (USD Million & Units)
5.3 Aneroid Sphygmomanometer
- 5.3.1 Market size, by region, 2018 - 2032 (USD Million & Units)
5.4 Digital Sphygmomanometer
- 5.4.1 Market size, by region, 2018 - 2032 (USD Million & Units)
- 5.4.2 Wrist Electronic Sphygmomanometer
  - 5.4.2.1 Market size, by region, 2018 - 2032 (USD Million & Units)
- 5.4.3 Arm Electronic Sphygmomanometer
  - 5.4.3.1 Market size, by region, 2018 - 2032 (USD Million & Units)

Chapter 6 Sphygmomanometer Market, By Operation

6.1 Key operation trends
6.2 Manual
- 6.2.1 Market size, by region, 2018 - 2032 (USD Million & Units)
6.3 Automatic
- 6.3.1 Market size, by region, 2018 - 2032 (USD Million & Units)
6.4 Semi-automatic
- 6.4.1 Market size, by region, 2018 - 2032 (USD Million & Units)

Chapter 7 Sphygmomanometer Market, By Configuration

7.1 Key configuration trends
7.2 Portable
- 7.2.1 Market size, by region, 2018 - 2032 (USD Million & Units)
7.3 Desk Mounted
- 7.3.1 Market size, by region, 2018 - 2032 (USD Million & Units)
7.4 Floor Standing
- 7.4.1 Market size, by region, 2018 - 2032 (USD Million & Units)
7.5 Wall Mounted
- 7.5.1 Market size, by region, 2018 - 2032 (USD Million & Units)

Chapter 8 Sphygmomanometer Market, By End-use

8.1 Key segment trends
8.2 Hospitals
- 8.2.1 Market size, by region, 2018 - 2032 (USD Million & Units)
8.3 Ambulatory Surgical Centers
- 8.3.1 Market size, by region, 2018 - 2032 (USD Million & Units)
8.4 Homecare
- 8.4.1 Market size, by region, 2018 - 2032 (USD Million & Units)
8.5 Others
- 8.5.1 Market size, by region, 2018 - 2032 (USD Million & Units)

Chapter 9 Sphygmomanometer Market, By Region

9.1 Key regional trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Poland
- 9.3.7 Netherlands
- 9.3.8 Sweden
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Taiwan
- 9.4.7 Indonesia
- 9.4.8 Philippines
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Columbia
- 9.5.5 Chile
- 9.5.6 Peru
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Egypt
- 9.6.5 Israel
- 9.6.6 Turkey

Chapter 10 Company Profiles

10.1 Acoma Medical Industry Co., Ltd
10.2 American Diagnostic Corporation
10.3 Amico Group of Companies
10.4 A&D Company, Limited
10.5 CIGA Healthcare Ltd.
10.6 CONTEC MEDICAL SYSTEMS CO., LTD.
10.7 HEINE Optotechnik GmbH & Co. KG
10.8 3B Scientific
10.9 Microlife Corporation
10.10 OMRON Corporation
10.11 Rossmax International Ltd.
10.12 Rudolf Riester GmbH (Halma Plc)
10.13 Spengler (The Spengler Holtex Group)
10.14 Sklar Surgical Instruments
10.15 Hill-Rom Services Inc. (Welch Allyn)

Sphygmomanometer Market - By Product, By Operation, By Configuration, By End-use & Global Forecast, 2023 - 2032